Drugs (Pharmaceuticals)

Subterms

    More stories

    • 75 Shares169 Views

      in Elections

      The Business of Being Chris Christie

      by

      Mr. Christie left the governor’s office in New Jersey and set out to, as he put it, “make money.” He successfully traded on his political profile — and on his ties to the man he now wants to defeat.As his second term as governor of New Jersey drew to a close in 2017, Chris Christie was characteristically blunt about his plans.“I want to have fun, and I want to make money,” he told The New York Times in an interview.Mr. Christie wasted no time. On his first day out of office, he saw Bruce Springsteen on Broadway. On his second, he met with executives of DraftKings, a fantasy sports behemoth that stood to benefit enormously from the Christie administration’s support for legalizing sports betting. The company later put the former governor on retainer to advise and influence state officials.Over the past six years, Mr. Christie has repeatedly capitalized, for personal gain, on the connections he made as one of the best-known governors in the country.He started a federal lobbying and consulting firm called Christie 55 Solutions, joined a multimillion-dollar real estate venture with a donor, landed a contract with ABC News, represented an international fugitive and sat on corporate boards, including that of his beloved New York Mets, the tortured baseball franchise run by his friend and megadonor, the billionaire Steve Cohen.And in 2018, the Christies bought a multimillion-dollar shorefront home in Bay Head, one of the more exclusive towns on the Jersey Shore. Their neighbors included, at one point, members of Bon Jovi. The business of being Chris Christie has received only sporadic attention since he left public office. But his latest enterprise — a presidential campaign bent on taking down former President Donald J. Trump, a man he once endorsed and advised — has cast a new light on his success.A close review of corporate and government records as well as interviews with more than 30 people familiar with his lobbying and consulting work shows Mr. Christie has profited from his relationship to the man he now wants to defeat, as well as from the political profile he gained in eight years as New Jersey’s governor.Mr. Christie has made millions from interests wanting to leverage his political ties, including pharmaceutical, medical and sports betting companies, like DraftKings — whose hiring of Mr. Christie has not been previously reported. Some had business with the state when Mr. Christie was governor, and saw him as a reliable advocate for their bottom line, while others were interested in tapping into his close association with Mr. Trump and the Trump administration.Christie 55 Solutions earned roughly $1.3 million in federal lobbying fees from April 2020 to April 2021, according to federal records. The firm also earned more than $800,000 in consulting fees from Pacira Biosciences, a pharmaceutical company with a significant presence in New Jersey. And he has earned around $400,000 a year for his work as a contributor to ABC News, according to a person familiar with the contract. Before he signed with ABC, multiple networks were interested in and were competing for Mr. Christie, another person familiar with the contract said. ABC later suspended its relationship with Mr. Christie before he began his campaign.The total value of Mr. Christie’s financial ventures is difficult to tabulate; much of his work involves corporate consulting, contracts that are not generally made public. Mr. Christie, who announced his bid in early June, has not yet been required to file a personal financial disclosure, a requirement for all federal candidates.Mr. Christie’s campaign declined both to comment on his finances and to disclose his post-governor clients and contracts.Mr. Christie at his campaign announcement. He has made millions from interests wanting to leverage his political ties.John Tully for The New York TimesFormer public officials from both parties regularly turn to political donors and corporate allies to make money. Former President Barack Obama earned $400,000 in a single speech from a Wall Street firm months after leaving office and later signed a production deal with Netflix, whose founder, Reed Hastings, is a major Democratic donor.No modern president comes close to Mr. Trump’s voluminous record of conflicts of interest, allegations of self-dealing and post-presidential deal-making that marked the Trump administration and its afterlife. His entanglements have spawned continued interest on the part of ethics experts, watchdog groups and federal prosecutors, who have issued subpoenas for information about his business dealings in foreign countries during his time in the White House.“The grift from this family is breathtaking,” Mr. Christie said at a recent town hall on CNN.While Mr. Christie’s own business ties don’t match Mr. Trump’s, they may test how far one more norm has been eroded in the Trump era: Registering as a lobbyist — a card-carrying member of the so-called swamp — has long been viewed as tantamount to retiring from electoral politics.Ambitious politicians typically tried to put distance between the “public office and the private interests they’re serving,” said Virginia Canter, the chief ethics counsel at the Citizens for Responsibility and Ethics in Washington, a nonpartisan watchdog group.“But if he’s got all of these other adjacent interests,” Ms. Canter said of Mr. Christie, “how impartial can you be?”‘The George Washington of legalized gaming’Retaining Mr. Christie was a natural move for DraftKings. As governor, he had been a leading force in the push to overturn the federal law that barred sports betting in most states. In 2018, when the Supreme Court decision in the case initially known as Christie vs. National Collegiate Athletic Association allowed states to legalize sports gambling, the industry rushed to push laws in states that would allow them to cash in on a new market.Weeks after the court’s ruling, Mr. Christie was the keynote speaker at a conference a gambling industry group hosted for state legislators in New Orleans, where he criticized sports leagues that had opposed expanding gambling.At the time, Mr. Christie was a consultant for Scientific Games, a lottery company that was part of a consortium that had won big when he privatized the New Jersey state lottery operations in 2013.The company was now seeking Mr. Christie’s advice on expanding into sports betting. Mr. Christie was paid more than $30,000 a month by Scientific Games, according to a person with knowledge of the arrangement who requested anonymity because the person was not authorized to discuss the contract.DraftKings also put Mr. Christie on a monthly retainer and then sent him to speak to state legislators, although he did not register as a state lobbyist.Soon after Mr. Christie left office, DraftKings put him on retainer to advise and influence state officials.AJ Mast for The New York TimesMr. Christie initially had broad appeal. His blue-state Republicanism made him popular with moderate lawmakers in the Northeast and Midwest, and his ties to then-President Trump gave him credibility with more right-wing legislators.“Having the George Washington of legalized gaming in the U.S. was obviously something we thought would be helpful,” said Jeremy Kudon, who worked for DraftKings and a rival, FanDuel, on joint lobbying efforts at the time and now runs a gambling industry trade association. “And his relationship with Trump we thought would be helpful.”But in late 2020, just as the sports gambling industry focused its lobbying efforts on conservative Southern states, Mr. Christie broke with Mr. Trump over the president’s false claims of a stolen election — and DraftKings stopped deploying him.A spokesman for the company declined to comment.An $800,000 New Jersey connectionMr. Christie has also worked closely with — and for — the pharmaceutical industry, one of the biggest economic drivers in his state.Just months after leaving office, Mr. Christie was tapped by Mr. Trump to lead the President’s Commission on Opioids, giving him a prominent national post on an issue he had made a major focus of his second term as governor.Among the industry executives the commission brought in to testify was David Stack, the chief executive of Pacira Biosciences. Mr. Stack pressed for a change in Medicare and Medicaid reimbursement policies, arguing, along with some policy experts, that the programs created incentives for doctors to prescribe opioids instead of non-opioid painkillers and other treatments that are less addictive.The commission included Mr. Stack’s suggestions in its final report and in 2018, the Centers for Medicare and Medicaid Services changed their policies for non-opioid treatments for pain, citing the recommendation from the Christie-led commission.The change benefited just one drug on the market at the time: Exparel, made by Pacira.Donald Trump chose Mr. Christie, a former rival who became a close adviser, to lead a commission on the opioid crisis. Mr. Christie later became a consultant and lobbyist for drug companies. Doug Mills/The New York TimesThat same year in 2018, Pacira paid $481,000 to Christie 55 Solutions for consulting work. In 2019, Pacira put Mr. Christie on its board and paid his firm $320,000, according to filings with the Securities and Exchange Commission. The reports did not offer any further details, and the company did not respond to questions about the payments.As of June 2022, Mr. Christie owned 3,486 Pacira Biosciences shares worth $207,034.Mr. Christie has said he was not employed by Pacira while serving on the opioids commission.Sara Marino, a spokeswoman for the company, said Mr. Christie “provided Pacira with valuable insight and guidance” as it sought “to provide an opioid alternative to as many patients as appropriate.”Mr. Christie has continued to consult for drug companies. In April, he joined the advisory board for Cytogel Pharma, a company testing a new non-opioid pain reliever in clinical trials.Dean Maglaris, the chief executive of Cytogel, said Mr. Christie had helped connect the young company with industry experts and government officials.“Being from New Jersey, which is the, probably the state with the largest population of pharmaceutical companies, he has put us in contact with people that he knows,” Mr. Maglaris said. Mr. Christie also helped connect the company with “folks in the federal government who have an abiding interest in solving the addiction crisis.”Negotiating with JusticeMr. Christie, a former federal prosecutor, also got involved in a high-profile money-laundering case. Mr. Christie was hired by Jho Low, a Malaysian businessman who had been indicted in 2018 on money laundering and bribery charges and was living as a fugitive. At the time, the U.S. government had seized hundreds of millions of dollars in assets tied to Mr. Low and associates.Mr. Christie never registered in court as an attorney for Mr. Low, but he worked behind the scenes to negotiate a deal with Justice Department lawyers. Mr. Low ultimately forfeited nearly all of the seized assets — with the exception of $15 million in payments to Mr. Christie and two law firms. Mr. Christie represented Jho Low, a Malaysian businessman who was indicted on money-laundering charges, in his negotiations with the Justice Department. Scott Roth/Invision, via Scott Roth/Invision/ApThe payout raised eyebrows among other lawyers involved. They saw it as a hefty sum for the legal work performed, but ultimately the Justice Department agreed to it, because the priority was to make sure Mr. Low did not have access to the money himself, according to people with knowledge of the negotiations.Although Mr. Christie had been using his connections in the Trump administration as a consultant for years, he did not register as a federal lobbyist until June 2020, shortly after the pandemic hit.As Congress passed several bills to help both businesses and health care providers, several major health care networks, all in New Jersey, hired Christie 55 Solutions: Atlantic Health System, RWJBarnabas Health and Hackensack Meridian Health each paid the firm $200,000 for a little less than a year’s work.Christie 55 Solutions, whose small staff included Mr. Christie’s wife, Mary Pat Christie, and Rich Bagger, his former chief of staff, closed its federal lobbying shop in late 2021.Seeing opportunity at homeAs he used his sway in Washington, Mr. Christie kept one foot in New Jersey. Both Mr. and Mrs. Christie joined a real estate venture with a New Jersey developer, Jon Hanson, a longtime political ally and fund-raiser for Mr. Christie’s campaigns.Mr. Christie’s involvement was announced in 2019 as the enterprise, named the Hampshire Christie Qualified Opportunity Fund, set out to find investors for real estate developments taking advantage of federal “opportunity zones,” a Republican-backed tax program intended to benefit low-income neighborhoods. The Trump administration program has been criticized as a windfall for wealthy developers.The Christies are “investor partners” in the fund and Mrs. Christie has helped raise some of the money, Mr. Hanson told The Times.Karl Rickett, a spokesman for the Christie campaign, said the former governor was never involved in the fund as a senior adviser or in any other capacity, and that the venture was entirely a project of Mrs. Christie’s.The fund has raised $80 million of its $250 million goal for three luxury housing and retail projects in Hackensack, N.J., and a New London, Conn., storage facility that will be developed by the firm Mr. Hanson founded, according to Mr. Hanson.When the fund was first publicized, Mrs. Christie promoted her husband’s involvement as an advantage, saying he would use his connections to smooth the path with New Jersey mayors, town councils and zoning boards.“Nobody really knows New Jersey as well as Chris, because he’s been at the helm for the last eight years,” she said to The Wall Street Journal at the time.Mr. Hanson, however, has said that has not happened. Mr. Christie has not been involved at the local level, he said.Kenneth P. Vogel More

    • 150 Shares99 Views

      in Elections

      Biden Is Running on His Record as President. Here’s Where He Stands.

      by

      President Biden has acknowledged that he has not accomplished all he wished to. But that, he maintains, is an argument for his re-election.WASHINGTON — Just hours after formally kicking off his re-election campaign, President Biden appeared on Tuesday before a crowd of union supporters chanting “four more years” to outline his case for a second term.In his telling, unsurprisingly, the record sounds pretty good — more jobs, more roads and bridges, more clean energy, more opportunities for workers without college degrees. In just two and a half years, he argued, he has helped restore America following a debilitating pandemic and societal collapse. “Our economic plan is working,” he maintained.But as with any incumbent seeking a renewal by voters, there is the record he is running on and the record he is running away from. During his address to more than 3,000 members of North America’s Building Trades Unions, Mr. Biden made no mention of the promises he has failed to achieve so far or the setbacks that have left him with some of the lowest approval ratings of a president at this point in their term.Mr. Biden’s record looks different depending on the angle from which it is viewed, all the more so in polarized times when voters and viewers migrate to their own corners of the information world for radically different vantage points. The president is either the mature leader fixing the country as he stands against the forces of evil or he is the leader of the forces of evil destroying the country.“Under my predecessor, infrastructure week became a punchline,” Mr. Biden told the union members, mocking former President Donald J. Trump’s failure to pass legislation rebuilding the nation’s worn public facilities that his successor did succeed in enacting. “On my watch, infrastructure has become a decade headline — a decade.”Mr. Trump, now seeking a rematch against Mr. Biden in 2024, gave his potential opponent no credit. “When I stand on that debate stage and compare our records,” he said in a statement, “it will be radical Democrats’ worst nightmare because there’s never been a record as bad as they have, and our country has never been through so much.”Along with the $1 trillion infrastructure package, which passed with Republican votes, Mr. Biden can boast of sweeping legislative victories that would have seemed improbable when he took office. Among other measures he pushed through a Congress with narrow Democratic majorities were a $1.9 trillion Covid-19 relief package; major investments to combat climate change; lower prescription drug costs for seniors; increased corporate taxes; expanded treatment for veterans exposed to toxic burn pits and incentives to turbocharge the semiconductor industry.He has been unable, however, to fulfill other major promises, including an assault weapons ban; an immigration overhaul providing a path to citizenship for migrants in the country illegally; two years of free community college; free universal preschool for all three- and four-year-olds; national paid sick leave; greater voting rights protections; and policing changes to counter excessive force. Some of those were never realistic in the first place, but Mr. Biden was the one to highlight them as priorities.His economic record is similarly complicated. More than 12 million jobs have been created since he took office as the economy bounced back from the pandemic, and unemployment is at or near its lowest level in a half-century. But inflation rocketed up to its highest level in four decades, which some critics blamed on excessive federal spending under Mr. Biden, although cost increases have been a global phenomenon. Likewise, gas prices shot up to record levels. While both have begun to come back down — inflation has fallen from 9 percent to 5 percent — Americans remain skittish about the economy, according to polls, and economists still worry about a possible recession.After fitful starts, Mr. Biden has presided over the easing of the Covid pandemic and accompanying restrictions despite vaccine resistance among many, especially on the political right. But he has failed to quell a surge of migration at the southwestern border, where attempted crossings have hit record highs, and Republicans blame him for a wave of crime, which actually began while Mr. Trump was still in office.Mr. Biden has worked to reverse Mr. Trump’s impact on the judiciary, pushing through more judicial appointments through the Senate in his first two years than his predecessor had, but the pipeline has slowed in recent months with the absence of an ailing Senator Dianne Feinstein, Democrat of California, from the Judiciary Committee. Mr. Biden fulfilled his promise to appoint the first Black woman to the Supreme Court, Ketanji Brown Jackson.Where he has not been able to work his will on lawmakers, he has relied on an expansive interpretation of his executive power to achieve policy goals, most notably his decision to forgive $400 billion in student loans. But such actions are inherently subject to court challenges, and analysts expect the Supreme Court to overrule the student loan decision.In the international arena, Mr. Biden worked to revitalize international ties that had frayed under Mr. Trump, recommitting to NATO and rejoining the Paris climate change accord. But his effort to resurrect the Iran nuclear agreement abandoned by Mr. Trump has gone nowhere.Mr. Biden’s withdrawal of American forces from Afghanistan after 20 years turned into a debacle, leading to a swift and brutal takeover of the country by the Taliban and a chaotic withdrawal of troops and allies, with fleeing Afghans swarming American planes and a suicide bomber killing 13 American troops and 170 civilians.Although Mr. Trump has criticized Mr. Biden over the episode, the president was carrying out a pullout deal that his predecessor struck with the Taliban, a pact that one of Mr. Trump’s own national security advisers called a “surrender agreement.” Some experts argue the fiasco at the Kabul airport emboldened President Vladimir V. Putin of Russia to assume that Mr. Biden was weak.But Mr. Biden rallied the world when Mr. Putin invaded Ukraine last year to isolate Moscow and cut off much of its financial ties with the West. With bipartisan support, Mr. Biden has committed more than $100 billion to arm Ukraine’s military and enable its government and people to survive the Russian onslaught. American assistance helped the Ukrainians surprise Russian invaders by preventing the takeover of their capital and most of the country, but the situation remains volatile.It remains volatile at home as well. Mr. Biden made the theme of his inaugural address his desire to unite the country after the divisions of the Trump years. And while he has to some extent lowered the temperature in Washington and worked at times with Republicans, America remains deeply polarized.Republicans accuse Mr. Biden of being the divisive one, citing his rhetoric assailing “MAGA Republicans” and blaming him for the investigations of his rival, Mr. Trump, although there is no evidence of involvement by the president.In his campaign kickoff video and subsequent speech on Tuesday, Mr. Biden acknowledged that he has not accomplished all he wished to. But that, he maintained, was an argument for his re-election. “We’ve got a lot more work to do,” he said. More

    • 163 Shares119 Views

      in Elections

      Biden Looks to Bolster Support Among Seniors With a Focus on Health Care

      by

      In a trip to Las Vegas, President Biden warned that Republicans would endanger popular programs like Social Security and Medicare.LAS VEGAS — One of President Biden’s promises to America’s seniors when he first campaigned for the Oval Office was this: You will pay less for health care.So on Wednesday, with a possible re-election announcement getting closer every day, the president traveled to Las Vegas to boast that millions of older adults would save on their medications thanks to the health care legislation he championed last year.Because of the Inflation Reduction Act, he said, seniors will no longer have to make co-payments for some recommended vaccines like shingles and tetanus, saving them an average of $70 each year in the future.“For seniors on fixed income who often need expensive medications to stay healthy, that constant question is can they take the medications and can they pay the bills without giving up important elements of their life,” Mr. Biden told an audience at the University of Nevada, Las Vegas.“It’s not just your health,” he said. “It’s about your dignity. It’s about your security.”In the 2020 election, Mr. Biden came up short among people 65 and older to former President Donald J. Trump, 48 percent to 52 percent. The president and his advisers are hoping to increase his support among that group in 2024 by arguing that its financial and medical security will be better protected with Mr. Biden in office.The centerpiece of that argument so far has been the fate of the government’s primary retirement programs, Social Security and Medicare. Mr. Biden has been aggressive in seizing on proposals by a handful of Republican politicians to argue that the party would put the popular programs in danger.He said as much on Wednesday, standing in front of a sign at the University of Nevada that said “Lowering Costs for American Families.” The president recounted his State of the Union speech this year, when several Republican lawmakers called him a liar for claiming that they wanted to cut the social safety net programs.“I hope it’s true,” he said, noting that the legislators were being filmed as they denied any interest in doing any damage to Medicare and Social Security. “But I’ll believe it when I see it,” he said.Beyond that issue, however, the administration argues that older Americans will also be grateful for the president’s efforts to keep costs down, especially when it comes to their medications, at a time when prices have been rising sharply.In addition to the $70 average savings on vaccines, White House officials said on Wednesday that seniors across the country would benefit from provisions in the Inflation Reduction Act that penalize drug companies when they increase the cost of a drug faster than inflation..css-1v2n82w{max-width:600px;width:calc(100% – 40px);margin-top:20px;margin-bottom:25px;height:auto;margin-left:auto;margin-right:auto;font-family:nyt-franklin;color:var(–color-content-secondary,#363636);}@media only screen and (max-width:480px){.css-1v2n82w{margin-left:20px;margin-right:20px;}}@media only screen and (min-width:1024px){.css-1v2n82w{width:600px;}}.css-161d8zr{width:40px;margin-bottom:18px;text-align:left;margin-left:0;color:var(–color-content-primary,#121212);border:1px solid var(–color-content-primary,#121212);}@media only screen and (max-width:480px){.css-161d8zr{width:30px;margin-bottom:15px;}}.css-tjtq43{line-height:25px;}@media only screen and (max-width:480px){.css-tjtq43{line-height:24px;}}.css-x1k33h{font-family:nyt-cheltenham;font-size:19px;font-weight:700;line-height:25px;}.css-1hvpcve{font-size:17px;font-weight:300;line-height:25px;}.css-1hvpcve em{font-style:italic;}.css-1hvpcve strong{font-weight:bold;}.css-1hvpcve a{font-weight:500;color:var(–color-content-secondary,#363636);}.css-1c013uz{margin-top:18px;margin-bottom:22px;}@media only screen and (max-width:480px){.css-1c013uz{font-size:14px;margin-top:15px;margin-bottom:20px;}}.css-1c013uz a{color:var(–color-signal-editorial,#326891);-webkit-text-decoration:underline;text-decoration:underline;font-weight:500;font-size:16px;}@media only screen and (max-width:480px){.css-1c013uz a{font-size:13px;}}.css-1c013uz a:hover{-webkit-text-decoration:none;text-decoration:none;}How Times reporters cover politics. We rely on our journalists to be independent observers. So while Times staff members may vote, they are not allowed to endorse or campaign for candidates or political causes. This includes participating in marches or rallies in support of a movement or giving money to, or raising money for, any political candidate or election cause.Learn more about our process.Officials said that 27 specialized drugs recently met that criteria, and that their makers would be required to pay rebates to the federal government for the extra costs. Administration officials said that older Americans might see some savings in the future as drug companies keep prices lower to avoid having to pay the rebates.“Some people with traditional Medicare or managed care Medicare may stand to save starting in just a matter of weeks,” Health and Human Services Secretary Xavier Becerra told reporters before the president’s appearance.Mr. Biden also highlighted the impact that his health care actions have had on the cost of insulin, which is a common — and usually expensive — drug for many seniors who suffer from diabetes.The president’s health care law caps the price of insulin at $35 per month for older adults, and Mr. Biden has succeeded in persuading two of the three biggest drug manufacturers to lower costs for younger people in need of insulin. Eli Lilly announced this month that it would cap out-of-pocket costs for insulin at the same $35. Novo Nordisk said it would cut the cost of its insulin drug by 75 percent.The focus on medical costs for older adults has been part of Mr. Biden’s agenda since before he became president. His campaign website said under the heading “The Biden Plan for Older Americans” that seniors in the United States “deserve to retire with dignity — able to pay for their prescriptions and with access to quality, affordable long-term care.”But his policy ambitions are now part of a political effort to win back some in that demographic who have trended toward Republicans as the average age of people living in the country increases each year.A group of about two-dozen Republican lawmakers is pushing legislation to repeal the Inflation Reduction Act, a move that White House officials and the president have seized on. Mr. Biden wants to make his Republican White House rival — whomever that turns out to be — pay for a repeal effort by suggesting that it will hurt older adults.In a statement last month, the White House said that efforts to repeal the law “would give tens of billions of dollars in subsidies back to Big Pharma, raise seniors’ prescription drug prices and raise taxes on an estimated 14.5 million people — all while increasing the deficit.”Mr. Biden’s visit to Las Vegas comes just weeks before he is expected to announce that he is running for a second term. Nevada is a critical swing state that Democrats need in their column if they want to retain control of the White House for another four years. In 2020, Mr. Biden won the state with 50.06 percent of the vote, to Mr. Trump’s 47.67 percent.Wednesday’s speech took place at the William F. Harrah College of Hospitality, a nod to the service unions that are extremely powerful in Las Vegas and an important Democratic constituency. More

    • 138 Shares159 Views

      in Elections

      As Midterms Near, Biden Warns Republicans Seek to Dismantle Democratic Legislation

      by

      The president told MSNBC that G.O.P. lawmakers could undo Democrats’ legislative victories if they regained control of Congress.WASHINGTON — President Biden warned on Friday that Republicans could upend legislative victories achieved under his administration and a Democratic Congress if the G.O.P. were to win control of Congress in November’s midterm elections.“They don’t have a platform other than to tear down what I’ve been able to do, we’ve been able to do.” Mr. Biden told an MSNBC news anchor, according to NBC News. “And I don’t know what they’re for.”He also vowed to veto a federal abortion ban if Republicans regain majorities of Congress and seek to pass such legislation. G.O.P. candidates have sought to avoid the subject as polls show a majority of voters support abortion rights.“The president has to sign it. I’ll veto it,” he said.Democrats pulled out a recent series of legislative victories heading into campaign season, after passing sweeping health, climate and tax legislation earlier this year. Those include an infusion of funding into America’s semiconductor industry to counter China and expanded medical benefits for veterans who were exposed to toxins from burn pits on military bases and a gun safety package.“These last several weeks all I’m doing is saying here’s what we’re for, here’s what they’re for and make a choice and vote,” Biden said in the interview with the MSNBC journalist Jonathan Capehart. “And I think people are going to show up and vote like they did last time.”The State of the 2022 Midterm ElectionsBoth parties are making their final pitches ahead of the Nov. 8 election.Where the Election Stands: As Republicans appear to be gaining an edge with swing voters in the final weeks of the contest for control of Congress, here’s a look at the state of the races for the House and Senate.Biden’s Low Profile: President Biden’s decision not to attend big campaign rallies reflects a low approval rating that makes him unwelcome in some congressional districts and states.What Young Voters Think: Twelve Americans under 30, all living in swing states, told The Times about their political priorities, ranging from the highly personal to the universal.In Minnesota: The race for attorney general in the light-blue state offers a pure test of which issue is likely to be more politically decisive: abortion rights or crime.Most recently, Mr. Biden vowed to wipe out up to $20,000 in student loan debt, which he touted on the campaign trail on Friday, noting that the program has received 22 million applications since it opened last week.But that plan was dealt a blow with a ruling by an appeals court Friday on a case brought by several Republican-led states. And a number of Republicans in Congress have targeted some of the administration’s key legislative measures..css-1v2n82w{max-width:600px;width:calc(100% – 40px);margin-top:20px;margin-bottom:25px;height:auto;margin-left:auto;margin-right:auto;font-family:nyt-franklin;color:var(–color-content-secondary,#363636);}@media only screen and (max-width:480px){.css-1v2n82w{margin-left:20px;margin-right:20px;}}@media only screen and (min-width:1024px){.css-1v2n82w{width:600px;}}.css-161d8zr{width:40px;margin-bottom:18px;text-align:left;margin-left:0;color:var(–color-content-primary,#121212);border:1px solid var(–color-content-primary,#121212);}@media only screen and (max-width:480px){.css-161d8zr{width:30px;margin-bottom:15px;}}.css-tjtq43{line-height:25px;}@media only screen and (max-width:480px){.css-tjtq43{line-height:24px;}}.css-x1k33h{font-family:nyt-cheltenham;font-size:19px;font-weight:700;line-height:25px;}.css-1hvpcve{font-size:17px;font-weight:300;line-height:25px;}.css-1hvpcve em{font-style:italic;}.css-1hvpcve strong{font-weight:bold;}.css-1hvpcve a{font-weight:500;color:var(–color-content-secondary,#363636);}.css-1c013uz{margin-top:18px;margin-bottom:22px;}@media only screen and (max-width:480px){.css-1c013uz{font-size:14px;margin-top:15px;margin-bottom:20px;}}.css-1c013uz a{color:var(–color-signal-editorial,#326891);-webkit-text-decoration:underline;text-decoration:underline;font-weight:500;font-size:16px;}@media only screen and (max-width:480px){.css-1c013uz a{font-size:13px;}}.css-1c013uz a:hover{-webkit-text-decoration:none;text-decoration:none;}How Times reporters cover politics. We rely on our journalists to be independent observers. So while Times staff members may vote, they are not allowed to endorse or campaign for candidates or political causes. This includes participating in marches or rallies in support of a movement or giving money to, or raising money for, any political candidate or election cause.Learn more about our process.Several House Republicans, including the top G.O.P. member of the committee that oversees entitlement programs such as Medicare and Medicaid, said they would back repealing the law that reduced prescription drug costs for seniors if their party took control of the House in November.Mr. Biden has previously warned that Republicans pose a threat to Social Security and Medicare, as Democrats paint the fate of America’s social safety net programs as a central campaign issue. He has also promised to continue to push forward on Democratic priorities in the next two years, like codifying abortion rights, strengthening gun control laws and instituting police reform, all measures that would be nonstarters with Republican majorities in the House and Senate.“What do you think they’re going to do?” Mr. Biden said at an event last month, criticizing a plan drafted by Senator Rick Scott, Republican of Florida, that would allow Social Security and Medicare to “sunset” if Congress did not extend the programs with new legislation.In his MSNBC interview, Mr. Biden dismissed polls that showed that the majority of voters disproved of his handling of the economy. A recent New York Times/Siena College poll found Republicans have an edge among likely voters going into November, with many voters citing worries about the economy, an issue on which Republican candidates have heavily campaigned.Mr. Biden has kept a low profile on the campaign trail, choosing to avoid rallies and instead touting his legislative victories in smaller events. He reiterated on Friday to MSNBC that he intends to seek re-election in 2024, though he said he had not made a formal decision. More

    • 138 Shares119 Views

      in Elections

      Biden Tries to Reassure Voters on Health Care Costs Before Election

      by

      At an event in Southern California, the president says his administration is working to keep costs down and warns that Republicans will drive prices higher if they gain power.LOS ANGELES — President Biden on Friday tried to reassure Americans stung by high inflation that his administration was working to keep health care costs down, promising a community college audience in Southern California that he was committed to doing even more.But his remarks in Irvine, Calif. — the first of two West Coast speeches devoted to health care costs — come just days after government data revealed that overall inflation remains high as voters prepare to go to the polls for midterm elections early next month.Surveys show that Americans are deeply frustrated by the impact of sharply higher prices on their pocketbooks. They are expected to rebuke the president and his party in the elections, with most analysts predicting that Democrats will lose control of one or both chambers in Congress.Speaking to a friendly audience, Mr. Biden argued that Republicans would drive prices higher if they gained power. He noted their opposition to his efforts to allow Medicare to negotiate drug prices, which he said would force prices down for medication for millions of seniors. And he said Democrats had pushed through price caps on critical drugs like insulin.“If Republicans in Congress have their way, it’s going to mean the power we just gave Medicare to negotiate lower prescription drug prices and other costs over time goes away — gone,” Mr. Biden said, standing in front of signs that said “Lowering Costs for American Families.” “Two-thousand-dollar cap on prescription drugs goes away — gone. The $35 month cap on insulin for Medicare is gone.”The State of the 2022 Midterm ElectionsWith the primaries over, both parties are shifting their focus to the general election on Nov. 8.The Final Stretch: With less than one month until Election Day, Republicans remain favored to take over the House, but momentum in the pitched battle for the Senate has seesawed back and forth.A Surprising Battleground: New York has emerged from a haywire redistricting cycle as perhaps the most consequential congressional battleground in the country. For Democrats, the uncertainty is particularly jarring.Arizona’s Governor’s Race: Democrats are openly expressing their alarm that Katie Hobbs, the party’s nominee for governor in the state, is fumbling a chance to defeat Kari Lake in one of the most closely watched races.Herschel Walker: The Republican Senate nominee in Georgia reportedly paid for an ex-girlfriend’s abortion, but members of his party have learned to tolerate his behavior.Mr. Biden’s three-state, four-day trip is also intended to boost the fortunes of Democratic candidates by using the presidential bully pulpit to highlight the party’s accomplishments. On Wednesday in Colorado, he stood next to Michael Bennet, one of the state’s two Democratic senators, to announce a new national monument — a key campaign promise for the embattled lawmaker.In Los Angeles on Thursday, Mr. Biden hailed the use of money from his infrastructure legislation to help complete a new subway line. During his remarks, he made certain to single out Representative Karen Bass, a Democrat who had fought for a provision that directs jobs on the project to local workers.“Local workers can be first in line for these jobs thanks to Karen,” Mr. Biden said. “I really mean it, Karen. Thank you very much.”At the community college in Irvine, Mr. Biden focused his attention on health care — and on Representative Katie Porter, a two-term Democrat running for re-election in a key swing district in Orange County.Ms. Porter, who is facing Scott Baugh, a Republican former state assemblyman, pushed for the drug pricing measure. At the event on Friday, Mr. Biden singled her out, crediting the success of Democratic legislation to her efforts to fight on behalf of her constituents..css-1v2n82w{max-width:600px;width:calc(100% – 40px);margin-top:20px;margin-bottom:25px;height:auto;margin-left:auto;margin-right:auto;font-family:nyt-franklin;color:var(–color-content-secondary,#363636);}@media only screen and (max-width:480px){.css-1v2n82w{margin-left:20px;margin-right:20px;}}@media only screen and (min-width:1024px){.css-1v2n82w{width:600px;}}.css-161d8zr{width:40px;margin-bottom:18px;text-align:left;margin-left:0;color:var(–color-content-primary,#121212);border:1px solid var(–color-content-primary,#121212);}@media only screen and (max-width:480px){.css-161d8zr{width:30px;margin-bottom:15px;}}.css-tjtq43{line-height:25px;}@media only screen and (max-width:480px){.css-tjtq43{line-height:24px;}}.css-x1k33h{font-family:nyt-cheltenham;font-size:19px;font-weight:700;line-height:25px;}.css-ok2gjs{font-size:17px;font-weight:300;line-height:25px;}.css-ok2gjs a{font-weight:500;color:var(–color-content-secondary,#363636);}.css-1c013uz{margin-top:18px;margin-bottom:22px;}@media only screen and (max-width:480px){.css-1c013uz{font-size:14px;margin-top:15px;margin-bottom:20px;}}.css-1c013uz a{color:var(–color-signal-editorial,#326891);-webkit-text-decoration:underline;text-decoration:underline;font-weight:500;font-size:16px;}@media only screen and (max-width:480px){.css-1c013uz a{font-size:13px;}}.css-1c013uz a:hover{-webkit-text-decoration:none;text-decoration:none;}How Times reporters cover politics. We rely on our journalists to be independent observers. So while Times staff members may vote, they are not allowed to endorse or campaign for candidates or political causes. This includes participating in marches or rallies in support of a movement or giving money to, or raising money for, any political candidate or election cause.Learn more about our process.“That’s why Katie’s leadership and the work of the Democrats in Congress was so consequential,” he said. “Katie, I’m not just being nice because I’m in your district. It happens to be true. No, no. I mean, you’re a fighter. You’re decent. You’re honorable and everybody respects you.”Friday’s event at the Irvine Valley Community College was an official one, not a campaign rally. But Ms. Porter used her time at the podium to assail Republicans.“Every single Republican in Washington voted against patients, against families and against taxpayers,” she said. “In the Senate, Republican politicians voted to limit how much Americans can save on prescription drugs and to prevent all patients from getting insulin. And House Republican Leader Kevin McCarthy has vowed that next term it’s his priority to return Big Pharma its unchecked power to charge patients whatever it wants.”She called that a “slap in the face” to the Californians she represents.Republicans sought to portray the president’s efforts to bolster candidates’ prospects as in vain. “Joe Biden is the last person Democrat candidates want to see on the campaign trail,” Michael McAdams, the communications director for the National Republican Campaign Committee, said after the event, noting reports that Democrats recently shifted money away from some California districts to candidates who need help more.“His policies are so unpopular House Democrats are being forced to abandon spending in California districts he won by double-digits,” Mr. McAdams said.Friday evening, Mr. Biden was scheduled to fly to Portland, Ore., a liberal community where the Democratic Party would not normally need the help of the sitting president. But Mr. Biden is hoping to help boost the fortunes of Tina Kotek, the Democratic candidate for governor.Although the state has not elected a Republican leader in decades, polls suggest that Ms. Kotek is in a tight, three-way race with Christine Drazan, the Republican candidate, and Betsy Johnson, a former Democrat who is being financed by Phil Knight, the co-founder of Nike. The White House is hoping that a visit by Mr. Biden will help underscore the party’s commitment to her.Republicans predicted that the president’s trip will not prevent their party from grabbing the top electoral prize in the state.“Joe Biden’s disastrous policies continue to hurt Oregon families, and there has been no bigger fan of his out-of-touch approach,” said Kaitlin Price, a spokeswoman for the Republican Governors Association, citing Ms. Kotek, Ms. Johnson and Kate Brown, the state’s current Democratic governor.“This last-ditch effort from national Democrats is proof of their hysteria as they watch Christine Drazan take hold of once deep-blue Oregon that is desperate for change,” Ms. Price said. More

    • 125 Shares119 Views

      in Elections

      Maybe Joe Biden Knows Joe Manchin Better Than We Thought

      by

      Gail Collins: Never really thought I’d be leading off with a toast to Joe Manchin, Bret, but troubled times require low expectations.Bret Stephens: You came around!Gail: Joe came around! Or caved, which sounds a little more satisfying. Of course we’ve still got his Senate colleague Kyrsten Sinema and her tax obsessions to worry about. But if it all comes together this week, we’ll get the big Biden program to battle climate change. Will that make you as happy as it would make me, hmm?Bret: Your happiness sounds like it’s an 8 or a 9 on a 10-point scale, and mine is probably around a 5. The Senate just passed a $280 billion bill to support the semiconductor industry under the guise of standing up to China, which is really just a huge giveaway to Intel and other U.S. chip makers. Now we’re dropping another $369 billion, and a lot of that will be in the form of corporate subsidies for companies like Tesla and General Motors. I know Manchin and Larry Summers are saying this will help bring down inflation. But pumping a lot of money into an economy usually has the opposite effect.On the other hand, it’s a whole lot less than the trillions the administration wanted to spend last year, so I’ll take that as a victory. It might keep the nuclear industry alive, which is also vital if we are serious about tackling climate change, and it might also reduce some of the permitting bottlenecks that get in the way of energy infrastructure. And the two bills are solid legislative wins for President Biden, who really, really needed them.Gail: As did all of us who are still Friends of Biden — although I guess we’d prefer not to be called F.O.B.s.Bret: Shame the news arrives the same week we get the second straight quarter of negative economic growth, which is … not a recession?Gail: I prefer to think of it as an, um, a very relaxed financial time.Bret: Not sure how much it would help Biden if he were to say, “Folks, the economy isn’t stalling. It’s relaxing.” Sorry, go on.Gail: And while of course politics is utterly beside the point — who in the world would worry about the entire makeup of Congress? — this legislation has got to help the Democrats come election time. Lots of good reasons we’re in an economic … slump. But you’ve got to be able to deliver a plan for making things better.One of my favorite parts of the bill is the way it clamps down on pharmaceutical companies. Like giving the government power to negotiate on the prices of some drugs covered by Medicare.Bret: Terrible! Price controls inevitably lead to less innovation, fewer incentives to manufacture generics and biosimilars and crazy distortions as pharmaceutical companies jack up the price of some drugs to make up for lost revenue in others. It’s just as bad an idea as rent control and rent stabilization, which is great for some but distorts the overall market and makes the city more expensive.Gail: Hey, we the taxpayers are funding those drugs and we should get assurance that all our money isn’t going to Big Pharma’s profits.Sorry, go on.Bret: I still don’t see the legislation swinging a lot of votes to the Democrats in the midterms. Biden also got his big infrastructure bill passed last year and it didn’t help him one bit politically. The only thing that can save the Democrats now is Donald Trump and his dumb political endorsements.Gail: Anybody you’re thinking of in particular? For instance, that dweeb Blake Masters in Arizona who we talked about recently? The one who now graciously admits he “went too far” when he wrote a youthful essay implicitly criticizing American involvement in World War II. I believe you said if you were voting in Arizona and Masters won the primary, you’d support the — hehehehe — incumbent Democrat, Mark Kelly.Bret: Yes, reluctantly. As David Sedaris might put it, the choice between Democrats and most Republicans these days is like a choice between a day-old baloney sandwich with a sad little pickle on a stale roll versus a plate of rancid chicken served with a sprinkling of anthrax on a bed of broken glass.I’ll take the sandwich.Gail: Got some other big primaries coming up on Tuesday besides Arizona. I’m sure a lot of Missouri Republicans would be happy to see the end of Eric Greitens, a former governor, who now seems to be fading in his run for the Senate. Can’t imagine why, given that he was forced to resign from office in an ethics crisis that included a mind-boggling sex scandal.Bret: The fact that he was the front-runner, at least until recently, really tells you that the G.O.P. has reached its psychotic stage. To recap, Greitens, a former Rhodes Scholar and Navy SEAL, resigned in disgrace as governor four years ago after barely a year in office. Later, his ex-wife alleged in a sworn affidavit, which Greitens disputes, that he knocked her down and confiscated her cellphone, wallet and keys to keep her and their children prisoner in their home. Also, that he was physically violent toward their 3-year-old son.Gail: Which really should have sealed the deal.Bret: More recently, he filmed an ad that was a live-action fantasy of shooting RINOs — “Republicans in Name Only” — that struck many of us as a pretty open invitation to violence. Even Josh Hawley thinks he’s vile, which is like Nikita Khrushchev taking a strong moral exception to Mao Zedong.Gail: Seems like his fading in the polls shouldn’t require a celebration, but we’ll take what we can get.Bret: As for Masters, his candidacy seems to rest on his promotion of so-called replacement theory.Gail: Yes, the idea that Democrats are encouraging immigration so they can create a minority-majority of voters.Bret: It’s almost amusing, since the most significant replacement to happen in Arizona was the one in which white settlers stole sovereign Mexican territory in an unprovoked invasion and dispossessed Native American tribes.Gail: Bless you.Bret: It’s also a master class in political malpractice, since it only alienates Hispanic voters, who are often fairly conservative and increasingly open to voting for Republicans. Are you feeling optimistic?Gail: Have to admit I’m kinda worried that a lot of liberal voters — particularly the younger ones — are just so appalled by the way things have been going with abortion and guns, and so depressed by the state of the economy, that they’ll just sit this one out.Bret: Yeah, but don’t discount the rancid chicken factor. As in, for instance, the Senate race in Georgia, or the governors’ races in Maryland and Pennsylvania.Gail: Well, just to stick with Georgia for a second, it does seem a guy like Herschel Walker, with a really dreadful performance record as a father, should have tried not to build his campaign around being a family-values candidate.Bret: With luck, maybe after a few losses Republican voters will finally get the message that a Trump endorsement in the primary is the political kiss of death in the general election.Then again, it would also help Democrats if someone cured Biden of his habit of saying things that quickly prove totally wrong. The other day he said there wasn’t going to be a recession. Before that, inflation was “temporary.” Last summer, it was that the Taliban wasn’t going to overrun Kabul. You can almost know what’s coming by expecting the opposite of whatever he predicts. That’s why I’m confident he won’t run for a second term. He keeps insisting that he will.Gail: I still don’t see any point in Biden’s announcing he won’t run this early in the calendar. He should wait until the end of the midterm elections. Then we can all turn our attention to the hordes of would-be successors waving their hands.That’ll still give Democrats a year to check out the options. Don’t you think that’s enough?Bret: If you’re the billionaire governor of Illinois, Jay Pritzker, it doesn’t make that much of a difference, since fund-raising isn’t an issue. Pete Buttigieg can’t be feeling as lucky. But either way I think it would be better for Biden to announce before the midterms. Maybe he will even find it liberating to be a president who can really govern for the rest of his term without the burden of a presumptive campaign and all the nagging questions about it. And it will send the message that he has the grace and wisdom to know it’s time to step aside, which is more than can be said for the Chuck Grassleys and Dianne Feinsteins of politics.Gail: Biden’s political clout, wobbly as it is right now, will vanish completely if he embraces lame-duck-hood. Announcing he’s not running by the end of the year seems a good timetable. But of course actually trying to stay in for another race would be a disaster.Bret: Gail, before we go we should probably mention that we’ll be taking the next two weeks off for travel and family. Any parting suggestions or recommendations for our readers till we reconvene?Gail: Stay cool, read something good — I’ve really been enjoying “A Gentleman in Moscow,” by Amor Towles, a novel about a count who’s trapped in his hotel after the Russian Revolution. That’s one for now, but when we get back, Bret, we’ve got to have that favorite-books conversation we’re always threatening to have.And what’s your tip?Bret: Same. Devote a few weekend mornings to some of the terrific longer pieces in The Times. Start with Alex Vadukul’s devastating, breathtaking portrait of Daniel Auster, Paul Auster’s son. It’s a modern-day “American Tragedy,” worthy of Dreiser. Then get out in the sun and count your life’s blessings. I hope there are many.The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: letters@nytimes.com.Follow The New York Times Opinion section on Facebook, Twitter (@NYTopinion) and Instagram. More

    • 100 Shares179 Views

      in Elections

      Boss Trump, ‘the Sorest Loser of All Time’

      by

      More from our inbox:Does Our Patent System Need to Be Reformed?Former President Donald J. Trump took the stage at a Save America rally in Michigan earlier this month.Brittany Greeson for The New York TimesTo the Editor:Re “The Mar-a-Lago Machine: Trump as a Modern-Day Party Boss” (front page, April 18):This disturbing and prescient article makes for painful reading. Everything that the hopeful pundits of 2020 predicted — that Donald Trump would fade away after his defeat, that he would run out of money, that his legal troubles would overwhelm him, that he would be exposed as a cheap, huckstering demagogue — has proved wrong.Instead he has emerged stronger than ever, with his legal troubles melting away, money pouring in and vast numbers of Americans fervently supporting him.Since 2020, those same hopeful pundits have been predicting that Mr. Trump won’t run in 2024 and that other Republicans somehow have a chance. But of course he will; why wouldn’t he? And when he does, he will be hard to beat.There is a kind of awful inevitability about Mr. Trump and his gang of Mar-a-Lago sycophants. It will be a dark day for our country if he once again becomes president.Tim ShawCambridge, Mass.To the Editor:“Trump’s Allies Keep Up Fight to Nullify Vote” (front page, April 19) is disturbing. But this never-ending effort to reverse the 2020 election keeps reminding everyone that Donald Trump is a loser — the sorest loser of all time.And one thing we know that Donald Trump detests is a loser.So as the months go by and turn into years, as the court cases and investigations proceed, Mr. Trump continues to remind us he is a loser. No matter how much he and his friends try, while defying facts, logic and the law, no matter how many tantrums he throws or lies he tells, he not only reminds us he’s a loser. He also reminds himself.Rick BeardsleyBoca Raton, Fla.Does Our Patent System Need to Be Reformed? Illustration by Rebecca Chew/The New York Times; photographs by Yevgen Romanenko, moi/amanaimagesRF, Westend61 and Marie Hickman, via Getty ImagesTo the Editor:Re “Save America’s Patent System” (editorial, Sunday Review, April 17):I commend The Times’s editorial board for making a compelling case for reform of our patent system. I have an incurable cancer. The drugs keeping me alive — which carry a list price of more than $900,000 annually — will one day stop working, so I care deeply about innovation and new drug development. But drugs don’t work if people can’t afford them.When a drug company makes a truly inventive discovery, it should be rewarded with a patent and receive a fair return. But the drug industry would have you believe that every patent granted is an indicator of innovative achievement. That couldn’t be further from the truth.In fact, the industry’s anti-competitive practices actually inhibit innovation. Neither new patents nor new drugs necessarily equal real innovation. Worse, in too many cases manufacturers are gaming America’s patent system to prevent competition and block affordable generic and biosimilar drugs from coming to market.We can — and should — bring down monopoly prices by empowering Medicare to negotiate, but we must also reform our patent system to address the drivers that lead to unjustified monopolies in the first place.David MitchellBethesda, Md.The writer is the founder of Patients for Affordable Drugs Now.To the Editor:America’s biopharmaceutical research companies support solutions that will lower health care costs, while some of the policies outlined in the editorial would simply harm patients.Biopharmaceutical innovation is difficult and risky, with only 12 percent of medicines in the pipeline entering clinical trials ever achieving F.D.A. approval. Patents play an essential role in encouraging innovation by helping fuel the investments that result in new treatments and cures.Patents do not establish a monopoly on treating a condition. Instead, they propel progress. A new patent on a product provides protection only for the invention it protects — it does not provide additional exclusivity for underlying products. Contrary to the editorial board’s assertion, the Patent and Trademark Office is not issuing sham patents.Drugmakers should continue researching ways their medicines can help tackle different diseases, treat new patient populations, like children, and make lifesaving treatments, like chemotherapy, more tolerable for patients. Progress is a good thing, and it should be encouraged, not punished.The Restoring the America Invents Act would benefit big patent infringers, like many big technology companies, and make the legal landscape more uncertain for researchers focused on bringing forward new medical advances for patients.Anne McDonald PritchettWashingtonThe writer is senior vice president, policy, research and membership, for the Pharmaceutical Research and Manufacturers of America.To the Editor:It shouldn’t be controversial to expect patented inventions to be new and useful, but it is. That’s because a handful of big companies treat the Patent Office like an A.T.M.: a reliable source of cash for the cost of a small fee. Because the Patent Office depends on those fees, it treats companies applying for protection like customers to be served instead of applicants to be evaluated. What about members of the public who depend on patented technology to earn a living, get an education, or access medical care? We get ignored.The editorial board is absolutely right: The patent system needs to change. But those who benefit from it most will fight tooth and nail to protect it. We need the new director of the Patent Office to prioritize the public’s interest and the patent system’s purpose — promoting scientific and technological progress — no matter how loud the cries of private companies accustomed to five-star service.Alex MossSouth Pasadena, Calif.The writer is executive director of the Public Interest Patent Law Institute.To the Editor:Your editorial wrongly targets our innovative insulin drug, Glargine, as an example of using patents to create a monopoly, ignoring that it has had biosimilar competition since 2016. Focusing on the patents for our delivery device is misleading because they have not prevented the development and sale of biosimilar Glargine products, let alone those with other non-infringing delivery methods.To make its case, the editorial board tied patents to the cost of medicine, which too many Americans struggle to afford. But Sanofi offers a comprehensive insulin safety net, giving uninsured patients ready access to free and low-cost insulin, while commercially insured patients all qualify for co-payment assistance that lowers out-of-pocket costs for most patients to $10 or less. And every Sanofi insulin is included in a Medicare program that caps costs for seniors.We are wary of imperiling a patent system that has put the U.S. first in biomedical innovation and generic drug penetration. We believe that the board would benefit readers by telling the complete story.Adam GluckWashingtonThe writer is senior vice president and head of U.S. corporate affairs at Sanofi. More

    • 163 Shares129 Views

      in Elections

      It’s All or Nothing for These Democrats, Even if That Means Biden Fails

      by

      If President Biden’s “Build Back Better” bill dies in Congress, it will be because moderate Democrats killed it.Over the past month, those moderates have put themselves at the center of negotiations over the $3.5 trillion proposal (doled out over 10 years) for new programs, investments and social spending. And they’ve made demands that threaten to derail the bill — and the rest of Biden’s agenda with it.In the House last week, a group of moderate Democrats successfully opposed a measure that would allow direct government negotiation of drug prices and help pay for the bill. One of the most popular items in the entire Democratic agenda — and a key campaign promise in the 2018 and 2020 elections — federal prescription drug negotiation was supposed to be a slam dunk. But the moderates say it would hurt innovation from drugmakers. Senator Kyrsten Sinema of Arizona has likewise announced her opposition to direct government negotiation of the price of prescription drugs.Similarly, a different group of moderate Democrats hopes to break the agreement between Democratic leadership and congressional progressives to link the Senate-negotiated bipartisan infrastructure bill to Biden’s “Build Back Better” proposal, which would be passed under the reconciliation process to avoid a filibuster by Senate Republicans.The point of the agreement was to win buy-in from all sides by tying the fate of one bill to the other. Either moderates and progressives get what they want or no one does. Progressive Democrats have held their end of the bargain. But moderates are threatening to derail both bills if they don’t get a vote on infrastructure before the end of the month. “If they delay the vote — or it goes down — then I think you can kiss reconciliation goodbye,” Representative Kurt Schrader of Oregon, one of the moderates, told Politico. “Reconciliation would be dead.”Of course, if the House were to vote on and pass the infrastructure bill before reconciliation was completed, there is a strong chance those moderates would leave the table altogether. Senator Joe Manchin of West Virginia, for example, wants to table the reconciliation bill. “Instead of rushing to spend trillions on new government programs and additional stimulus funding, Congress should hit a strategic pause on the budget-reconciliation legislation,” Manchin wrote this month.Moderate Democrats want Biden to sign the bipartisan infrastructure bill. But it seems clear that they’ll take nothing if it means they can trim progressive sails in the process, despite the fact that many of the items in the “Build Back Better” bill are the most popular parts of the Democratic agenda.Here, it’s worth making a larger point. In the popular understanding of American politics, the term “moderate” or “centrist” usually denotes a person who supports the aims and objectives of his or her political party but prefers a less aggressive and more incremental approach. It is the difference between a progressive or liberal Democrat who wants to expand health coverage with a new, universal program (“Medicare for All”) and one who wants to do the same by building on existing policies, one step at a time.Moderates, it’s commonly believed, have a better sense of the American electorate and thus a better sense of the possible. And if they can almost always count on favorable and flattering coverage from the political press, it is because their image is that of the “grown-ups” of American politics, whose hard-nosed realism and deference to public opinion stands in contrast to the fanciful dreams of their supposedly more out-of-touch colleagues.Given this picture of the ideological divide within parties, a casual observer might assume that in the struggle to move President Biden’s agenda through Congress, the chief obstacle (beyond Republican opposition) is the progressive wing of the Democratic Party and its demands for bigger, more ambitious programs. Biden was, after all, not their first choice for president. Or their second. He won the Democratic presidential nomination over progressive opposition, and there was a sense on the left, throughout the campaign, that Biden was not (and would not be) ready to deal with the scale of challenges ahead of him or the country.But that casual observer would be wrong. Progressives have been critical of Biden, especially on immigration and foreign affairs. On domestic policy, however, they’ve been strong team players, partners in pushing the president’s priorities through Congress. The reconciliation bill, for instance, is as much the work of Bernie Sanders as it is of the White House. As chairman of the Senate Budget Committee, Sanders guided the initial budget resolution through the chamber, compromising on his priorities in order to build consensus with other Democrats in the Senate.Progressive Democrats want the bill to pass, even if it isn’t as large as they would like. They believe, correctly, that a win for Biden is a win for them. Moderate Democrats, however, seem to think that their success depends on their distance from the president and his progressive allies. Their obstruction might hurt Biden, but, they seem to believe, it won’t hurt them.This is nonsense. Democrats will either rise together in next year’s elections or they’ll fall together. The best approach, given the strong relationship between presidential popularity and a party’s midterm performance, is to put as much of Biden’s agenda into law as possible by whatever means possible.But this would demand a more unapologetically partisan approach, and that is where the real divide between moderates and progressives emerges. Moderate and centrist Democrats seem to value a bipartisan process more than they do any particular policy outcome or ideological goal.The most charitable explanation is that they believe that their constituents value displays of bipartisanship more than any new law or benefit. A less charitable explanation is that they see bipartisanship as a way to clip the wings of Democratic Party ambition and save themselves from taking votes that might put them in conflict with either voters or donors.What is true of both explanations is that they show the extent to which moderate Democrats have made a fetish of bipartisan displays and anti-partisan feeling. And in doing so, they reveal that they are most assuredly not the adults in the room of American politics.There is nothing serious about an obsession with the most superficial aspects of process over actual policy and nothing savvy about leaving real problems unaddressed in order to score points with some imagined referee.The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: letters@nytimes.com.Follow The New York Times Opinion section on Facebook, Twitter (@NYTopinion) and Instagram. More